Current Oncology Reports

, 18:40

The Use of Medical Marijuana in Cancer

  • Shauna M. Birdsall
  • Timothy C. Birdsall
  • Lucas A. Tims
Integrative Care (C Lammersfeld, Section Editor)

DOI: 10.1007/s11912-016-0530-0

Cite this article as:
Birdsall, S.M., Birdsall, T.C. & Tims, L.A. Curr Oncol Rep (2016) 18: 40. doi:10.1007/s11912-016-0530-0
Part of the following topical collections:
  1. Topical Collection on Integrative Care

Abstract

The use of medical marijuana in cancer care presents a dilemma for both patients and physicians. The scientific evidence is evolving, yet much of the known information is still insufficient to adequately inform patients as to risks and benefits. In addition, evidence-based dosing and administration information on medical marijuana is lacking. Medical marijuana is now legal, on some level, in 24 states plus the District of Columbia, yet is not legal on the federal level. This review addresses the current state of the research, including potential indications, risks and adverse effects, preliminary data on anticancer effects, as well as legal and quality issues. A summary of the clinical trials underway on medical marijuana in the oncology setting is discussed.

Keywords

Marijuana Cannabis Cancer Delta-9-tetrahydrocannabinol Delta-9-THC Tetrahydrocannabinol THC Cannabinoid Cannabidiol CBD Endocannabinoid Oncology Dronabinol Nabilone Nabiximols 

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Shauna M. Birdsall
    • 1
  • Timothy C. Birdsall
    • 1
  • Lucas A. Tims
    • 1
  1. 1.Cancer Treatment Centers of America at Western Regional Medical CenterGoodyearUSA

Personalised recommendations